Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2 is a research paper published in Molecular Therapy — Methods & Clinical Development (2020). On theSindex it has a DataRank of 0.578. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.578
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Health and Medical Research Council
Grant: APP1108311
National Health and Medical Research Council
Grant: APP1156431
National Health and Medical Research Council
Grant: APP1161583
National Stroke Foundation
Grant: DMS 1563234
National Institutes of Health
Grant: R01 GM082946
National Science Center, Republic of Poland
Grant: UMO-2017/25/B/NZ1/02790
Department of Science and Higher Education of Ministry of National Defense, Republic of Poland
Grant: (“Kościuszko” k/10/8047/DNiSW/T–WIHE/3
Wellcome Trust
Grant: unidentified
unidentified
National Health and Medical Research Council (NHMRC)
Grant: 1108311
Directed evolution of AAV capsid variants for enhanced targeted genome editing in the human liver
National Institutes of Health
Grant: 2R01GM082946-06A1
AAV capsids and their cellular interactions
Children’s Medical Research Institute
Wellcome Trust Principal Research Fellow
Wellcome Trust
Wellcome Trust
FWCI
4.17
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals